Wegovy is the version of semaglutide specifically approved for weight loss and weight management in adults with obesity or overweight with related comorbidities
incl endometrial biopsy, PAP smear, blood tests
In humans, two stereospecific families of methionine sulfoxide reductases (MsrA and MsrB) are encoded by a single MSRA gene and three MSRB genes ( MSRB1-3 )
Factors such as diabetes, obesity, fertility history, previous pregnancy complications, and overall health can all influence the best path forward
Your care plan may include GLP-1 therapy, hormone optimization, disease management, nutrition, lifestyle medicine, supplements, and targeted metabolic support